Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Fraser

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Current Eye Research|January 1, 1991
A review of the molecular mechanism of HSV-1 latencyN W Fraser, J G Spivack, Z Wroblewska, et al.
The EMBO Journal|February 1, 1989
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infectionI Steiner, J G Spivack, R P Lirette, et al.
Journal of Virology|April 10, 1999
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cellsY H Su, R L Meegalla, R Chowhan, et al.
Virology|June 12, 1999
The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systemsR Tal-Singer, R Pichyangkura, E Chung, et al.
Academic Radiology|February 24, 2001
T1rho imaging of murine brain tumors at 4 TH Poptani, U Duvvuri, C G Miller, et al.
Virology|September 15, 1996
Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivoB P Randazzo, J C Kucharczuk, L A Litzky, et al.
Journal of Neurovirology|June 1, 1997
Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA boxW A Tatarowicz, C E Martin, A S Pekosz, et al.
Journal of Virology|December 1, 1991
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye modelM D Trousdale, I Steiner, J G Spivack, et al.
The Journal of General Virology|August 1, 1994
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID miceT Valyi-Nagy, M U Fareed, J S O'Keefe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutantS Kesari, B P Randazzo, T Valyi-Nagy, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Current Eye Research|January 1, 1991
A review of the molecular mechanism of HSV-1 latencyN W Fraser, J G Spivack, Z Wroblewska, et al.
The EMBO Journal|February 1, 1989
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infectionI Steiner, J G Spivack, R P Lirette, et al.
Journal of Virology|April 10, 1999
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cellsY H Su, R L Meegalla, R Chowhan, et al.
Virology|June 12, 1999
The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systemsR Tal-Singer, R Pichyangkura, E Chung, et al.
Academic Radiology|February 24, 2001
T1rho imaging of murine brain tumors at 4 TH Poptani, U Duvvuri, C G Miller, et al.
Virology|September 15, 1996
Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivoB P Randazzo, J C Kucharczuk, L A Litzky, et al.
Journal of Neurovirology|June 1, 1997
Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA boxW A Tatarowicz, C E Martin, A S Pekosz, et al.
Journal of Virology|December 1, 1991
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye modelM D Trousdale, I Steiner, J G Spivack, et al.
The Journal of General Virology|August 1, 1994
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID miceT Valyi-Nagy, M U Fareed, J S O'Keefe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutantS Kesari, B P Randazzo, T Valyi-Nagy, et al.
Pageof 12